Sabra Health Care Financial Statements (SBRA)
|
|
|
|
Report date
|
|
|
22.02.2022 |
20.03.2023 |
27.02.2024 |
19.02.2025 |
12.02.2026 |
|
29.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
569.5 |
624.8 |
647.5 |
703.2 |
774.6 |
|
812.8 |
|
Operating Income, bln rub |
|
|
210.7 |
234.8 |
221.7 |
257.0 |
263.9 |
|
235.6 |
|
EBITDA, bln rub |
? |
|
166.2 |
216.9 |
311.8 |
412.6 |
456.8 |
|
438.1 |
|
Net profit, bln rub |
? |
|
-113.3 |
-77.6 |
13.8 |
126.7 |
155.6 |
|
156.2 |
|
|
OCF, bln rub |
? |
|
356.4 |
315.7 |
300.6 |
310.5 |
348.6 |
|
366.7 |
|
CAPEX, bln rub |
? |
|
33.6 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
FCF, bln rub |
? |
|
322.8 |
315.7 |
300.6 |
310.5 |
348.6 |
|
366.7 |
|
Dividend payout, bln rub
|
|
|
262.9 |
277.2 |
277.4 |
280.2 |
289.5 |
|
293.8 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
2 017% |
221.1% |
186.0% |
|
188.1% |
|
|
OPEX, bln rub |
|
|
217.6 |
227.4 |
230.6 |
219.1 |
239.7 |
|
280.5 |
|
Cost of production, bln rub |
|
|
141.2 |
162.6 |
195.2 |
227.1 |
271.1 |
|
296.8 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
98.6 |
105.5 |
113.0 |
115.3 |
112.5 |
|
115.9 |
|
|
Assets, bln rub |
|
|
5 967 |
5 748 |
5 386 |
5 304 |
5 493 |
|
5 591 |
|
Net Assets, bln rub |
? |
|
3 380 |
3 056 |
2 803 |
2 741 |
2 822 |
|
2 786 |
|
Debt, bln rub |
|
|
2 444 |
2 549 |
2 447 |
2 444 |
2 550 |
|
2 693 |
|
Cash, bln rub |
|
|
112.0 |
49.3 |
41.3 |
60.5 |
71.5 |
|
123.5 |
|
Net debt, bln rub |
|
|
2 332 |
2 500 |
2 405 |
2 384 |
2 479 |
|
2 569 |
|
|
Ordinary share price, rub |
|
|
13.5 |
12.4 |
14.3 |
17.3 |
18.9 |
|
20.7 |
|
Number of ordinary shares, mln |
|
|
219.1 |
230.9 |
231.2 |
233.5 |
241.3 |
|
252.1 |
|
|
Market cap, bln rub |
|
|
2 966 |
2 871 |
3 299 |
4 044 |
4 570 |
|
5 224 |
|
EV, bln rub |
? |
|
5 298 |
5 370 |
5 705 |
6 428 |
7 049 |
|
7 793 |
|
Book value, bln rub |
|
|
3 325 |
3 016 |
2 772 |
2 714 |
2 757 |
|
2 719 |
|
|
EPS, rub |
? |
|
-0.52 |
-0.34 |
0.06 |
0.54 |
0.64 |
|
0.62 |
|
FCF/share, rub |
|
|
1.47 |
1.37 |
1.30 |
1.33 |
1.44 |
|
1.45 |
|
BV/share, rub |
|
|
15.2 |
13.1 |
12.0 |
11.6 |
11.4 |
|
10.8 |
|
|
EBITDA margin, % |
? |
|
29.2% |
34.7% |
48.2% |
58.7% |
59.0% |
|
53.9% |
|
Net margin, % |
? |
|
-19.9% |
-12.4% |
2.12% |
18.0% |
20.1% |
|
19.2% |
|
FCF yield, % |
? |
|
10.9% |
11.0% |
9.11% |
7.68% |
7.63% |
|
7.02% |
|
ROE, % |
? |
|
-3.35% |
-2.54% |
0.49% |
4.62% |
5.51% |
|
5.61% |
|
ROA, % |
? |
|
-1.90% |
-1.35% |
0.26% |
2.39% |
2.83% |
|
2.79% |
|
|
P/E |
? |
|
-26.2 |
-37.0 |
239.8 |
31.9 |
29.4 |
|
33.4 |
|
P/FCF |
|
|
9.19 |
9.09 |
11.0 |
13.0 |
13.1 |
|
14.2 |
|
P/S |
? |
|
5.21 |
4.59 |
5.10 |
5.75 |
5.90 |
|
6.43 |
|
P/BV |
? |
|
0.89 |
0.95 |
1.19 |
1.49 |
1.66 |
|
1.92 |
|
EV/EBITDA |
? |
|
31.9 |
24.8 |
18.3 |
15.6 |
15.4 |
|
17.8 |
|
Debt/EBITDA |
|
|
14.0 |
11.5 |
7.71 |
5.78 |
5.43 |
|
5.86 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
|
|
|
|
|
|
|
|
CAPEX/Revenue, % |
|
|
5.90% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
| Sabra Health Care shareholders |
